Online citations, reference lists, and bibliographies.
← Back to Search

Survival Of Malignant Mesothelioma And Other Rare Thoracic Cancers In Germany And The United States: A Population‐based Study

E. Sirri, J. Kieschke, C. Vohmann, A. Katalinic, A. Nennecke, M. Ressing, A. Eberle, B. Holleczek, L. Jansen, H. Brenner
Published 2020 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Evidence on survival of malignant mesothelioma (MM) and other rare thoracic cancers is limited due to the rarity of these cancer sites. Here, we provide a comprehensive overview of MM incidence and survival after MM and other rare thoracic cancers in Germany and the United States (US). Incidence was estimated from a German National Cancer Database and from the Surveillance, Epidemiology and End Results (SEER) 18 database for 2000–2014. Patients diagnosed in 1997–2013 with malignant epithelial tumors of the trachea (Etra), epithelial tumors of the thymus (Ethy) and MM were extracted from a German cancer survival database and from the SEER 13 database. Period analysis was employed to compute 5‐year relative survival (RS). During 2000–2014, an annual average of 0.9 and 0.6 MM cases per 100,000 person‐years was diagnosed in Germany and the US. Rates decreased in Germany and in the US. Patients with Ethy had highest 5‐year RS with US patients surviving longer (69.1% compared to 63.7%, p = 0.02). Survival after Etra was comparable in both countries (Germany 33.6%, US 34.4%, p = 0.07). Survival in MM patients was poor overall (Germany 11.8%, US 12.1%, p < 0.01). Survival improvements were only observed in MM patients in Germany (10.8% [2002–2007] vs. 13.0% [2008–2013], p < 0.01). The lack of progress in survival for Etra and Ethy patients underlines the need of novel preventive, therapeutic and diagnostic approaches. MM incidence significantly decreased in Germany and in the US. Further monitoring of MM incidence is warranted given that a peak in incidence is expected in 2020–2030 in Western countries.
This paper references
10.3389/fgene.2014.00151
Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?
B. Kerger (2014)
10.1016/J.EJCA.2004.07.002
Standard cancer patient population for age standardising survival ratios.
I. Corazziari (2004)
10.21037/atm.2017.04.29
Mesothelioma: recent highlights.
M. Carbone (2017)
10.1007/s10552-013-0203-3
The effect of multiple primary rules on population-based cancer survival
H. Weir (2013)
10.1177/000271629100100410
List
F. Marletta (1891)
10.18632/oncotarget.12809
Marital status is an independent prognostic factor for tracheal cancer patients: an analysis of the SEER database
M. Li (2016)
10.1007/978-3-642-85851-2
Cancer Incidence in Five Continents
Freddie Ian Bray (1970)
10.1200/jco.2011.29.15_suppl.7023
Thymoma: A population-based study of the management and outcomes for the province of British Columbia.
C. Mariano (2011)
10.1111/j.1755-3768.2014.1622.x
Relative survival
B. D'amato (2014)
10.1016/j.ejso.2018.01.078
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting.
M. Imbimbo (2019)
10.1016/S0140-6736(17)30819-X
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015
Marissa B Nancy Marie Joseph S Amanuel Kalkidan Hassen Cri Reitsma Fullman Ng Salama Abajobir Abate Abbafati (2017)
10.1007/s12253-009-9170-0
Differential Expression of Ki-67 and Sex Steroid Hormone Receptors Between Genders in Peritoneal Mesothelioma
Terence C. Chua (2009)
a systematic analysis from the Global Burden of Disease Study
(1990)
of Health and Human Services
U. S Departmen (2018)
10.1038/nrc3497
How ageing processes influence cancer
J. P. Magalhães (2013)
10.1002/ijc.23874
Survival of pleural malignant mesothelioma in Italy: A population‐based study
F. Montanaro (2009)
10.3389/fgene.2014.00001
Cytoplasmic 5′-3′ exonuclease Xrn1p is also a genome-wide transcription factor in yeast
D. A. Medina (2014)
Thymic epithelial tumors: a clinicopathologic study of 249 cases from a single institution.
Xue-ying Su (2014)
10.1093/jnci/djr483
Preventable exposures associated with human cancers.
V. Cogliano (2011)
10.1002/ijc.29316
Recent cancer survival in Germany: An analysis of common and less common cancers
L. Jansen (2015)
10.1016/J.JAMCOLLSURG.2005.09.016
Primary tracheal malignant neoplasms: the University of Texas MD Anderson Cancer Center experience.
B. D. Webb (2006)
10.1002/lary.24123
Management and prognosis of primary tracheal cancer: A national analysis
S. Mahmoud Nouraei (2014)
Treatment Results and Prognostic Indicators in Thymic Epithelial Tumors: A Clinicopathological Analysis of 45 Patients
M. Ansari (2014)
Surveillance, Epidemiology, and End Results (SEER) program research data
(1973)
10.1200/JCO.20.3.826
Up-to-date long-term survival curves of patients with cancer by period analysis.
H. Brenner (2002)
10.1016/S0959-8049(02)00003-5
A computer program for period analysis of cancer patient survival.
H. Brenner (2002)
Statistical Methodology and Applications Branch, Surveillance Research Program
10.1158/0008-5472.CAN-08-4523
Estrogen receptor-beta affects the prognosis of human malignant mesothelioma.
G. Pinton (2009)
10.1093/annonc/mdr131
Survival from common and rare cancers in Germany in the early 21st century.
E. Hiripi (2012)
National Asbestos Profile for Germany, 1. edn. Dortmund: Bundesanstalt für Arbeitsschutz und Arbeitsmedizin
(2014)
10.1158/1055-9965.EPI-11-0697
Deriving Valid Population–Based Cancer Survival Estimates in the Presence of Nonnegligible Proportions of Cancers Notified by Death Certificates Only
H. Brenner (2011)
10.21037/acs.2018.03.04
Overview of malignant tracheal tumors.
M. Madariaga (2018)
SEER) Program SEER*Stat database: incidence-SEER 18 Regs research data+Hurricane Katrina impacted Louisiana cases
Epidemiology Surveillance (2000)
Instructions to IBM 650 programmers in processing survival
F Ederer (1959)
10.1016/j.ejca.2011.05.028
Reduction of population-based cancer survival estimates by trace back of death certificate notifications: an empirical illustration.
B. Holleczek (2012)
2020 The Authors
(2020)
10.1093/annonc/mdr477
Importance of gender in diffuse malignant peritoneal mesothelioma.
C. Cao (2012)
10.4103/0019-5278.146897
Global mesothelioma epidemic: Trend and features
C. Bianchi (2014)
10.1093/AJE/KWJ243
Up-to-date and precise estimates of cancer patient survival: model-based period analysis.
H. Brenner (2006)
10.1002/bjs.5377
Sex difference in diffuse malignant peritoneal mesothelioma
T. Yan (2006)
10.1016/j.ejca.2012.02.047
Rare thoracic cancers, including peritoneum mesothelioma.
S. Siesling (2012)
Asbestos bodies in lung tissue are associated with pathologic features and patient outcome for epithelial but not non-epithelial mesothelioma treated by extrapleural pneumonectomy
W. Richards (2009)
10.1097/JTO.0b013e3181f1cf2b
Malignant Pleural Mesothelioma: A Population-Based Study of Survival
M. Milano (2010)
Instructions to IBM 650 programmers in processing survival computations
F Ederer (1959)
Association of Population-based Cancer Registries in Germany (GEKID): Cancer incidence and mortality atlas in Germany. www.gekid.de, data update
10.1002/ijc.27545
Full dates (day, month, year) should be used in population‐based cancer survival studies
L. Woods (2012)
10.1016/j.athoracsur.2010.04.110
Characteristics of malignant pleural mesothelioma in women.
A. Wolf (2010)
Poor prognosis in elderly patients with cancer: the role of bias and undertreatment.
D. Dale (2003)
Surveillance Research Program, National Cancer Institute SEER*Stat software. Version 8.3.5 www. seer.cancer.gov/seerstat
10.1179/2049396712Y.0000000016
Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003–2008
S. Jane Henley (2013)
10.1097/COC.0b013e3181cae8ab
Population Based Cancer Registry Analysis of Primary Tracheal Carcinoma
A. Urdaneta (2011)
10.1016/j.ejca.2012.09.029
Determinants and interpretation of death certificate only proportions in the initial years of newly established cancer registries.
H. Brenner (2013)
Center for Cancer Registry Data: www.krebsdate. de/abfrage; Data submission
Relative survival rate.
J. M. Bae (2004)
10.1023/A:1014380323037
Projecting SEER cancer survival rates to the US: an ecological regression approach
A. Mariotto (2004)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar